GL1X · GenesisL1 explorer

Research workbench

4-substituted trinems as broad spectrum-lactamase inhibitors: structure-based design, synthesis and biological activity

Analyse 4-substituted trinems as broad spectrum-lactamase inhibitors: structure-based… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2Q9N
Type
protein
Length
359 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase
EC
3.5.2.6
UniProt
P05364
Ligands
LK5
Pockets
2 · best druggability 0.67

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactamase (EC 3.5.2.6)protein35940% helix, 22% strandP05364

Ligands and binding sites

  • LK5 · (1s,4r,7ar)-4-butoxy-1-[(1R)-1-formylpropyl]-2,4,5,6,7,7A-hexahydro-1H-isoindole-3-carboxylic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13930.670.8044LK5
2960.340.7318empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 2Q9N · 4-Substituted Trinems as Broad Spectrum-Lactamase Inhibitors: Structure-based Design… · the same entry in another collection · chain A against A, TM-score 1.00
  • P05364 · AlphaFold monomer V2.0 prediction for beta-lactamase (P05364) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.